跳至主要内容
临床试验/NCT05197088
NCT05197088Unknown3 期

Medication Facilitated Ureteral Access Sheath Deployment During Ureteroscopy: the Impact of One Week of Pre-operative Tamsulosin

Sengkang General Hospital0 个研究点目标入组 110 人开始时间: 2022年1月9日最近更新:
适应症
干预措施

试验速览

阶段
3 期
发起方
入组人数
110
主要终点
successful insertion of ureteral access sheath to the upper ureter (above the level of SI joint on fluoroscopy)

研究概览

简要总结

Aim is to study if 1 week of pre operative tamsulosin would enable easier insertion of ureteral access sheath in primary retrograde intrarenal surgery for renal stone disease

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Double (Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • renal stone undergoing retrograde intrarenal surgery

排除标准

  • not on tamsulosin or other alpha blockers regularly
  • ureteral stricture
  • concurrent ureteric stone

研究组 & 干预措施

1 week of tamsulosin

Experimental

1 week of tamsulosin tablet 400mcg once a night

干预措施: Tamsulosin (Drug)

结局指标

主要结局

successful insertion of ureteral access sheath to the upper ureter (above the level of SI joint on fluoroscopy)

时间窗: during operation

次要结局

  • grade of ureteric injury after ureteral access sheath removal(during operation)
  • stone free rate(3 months)
  • need for additional procedures(3 months)
  • post operative complications(3 months)

研究者

发起方
Sengkang General Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sundaram Palaniappan

Dr

Sengkang General Hospital

相似试验